Brello Health is a U.S. telehealth platform that prescribes compounded semaglutide and tirzepatide for weight loss, starting at $133 per month. The Houston-based company serves over 80,000 active members through a fully online process with no in-person visits required.

Brello positions itself as the budget-friendly option in the compounded GLP-1 market. Its semaglutide plan starts at $399 for a 3-month supply — roughly half what competing platforms charge monthly. But that low price comes with documented tradeoffs: shipping delays measured in weeks, light medical screening, unnamed pharmacy partners, and billing complaints that have generated BBB filings.

Here is a full breakdown of what Brello Health offers, what real users report, and whether the price advantage is worth the tradeoffs.

Table of Contents

What Is Brello Health?

Brello Health is a U.S. telehealth platform founded in Houston, Texas that connects patients with licensed clinicians for compounded GLP-1 weight loss medications delivered directly to their door. The company serves over 80,000 active members across 49 states. The platform does not operate as a direct medical provider — it acts as a connector between patients, clinicians, and compounding pharmacies.

The service targets adults seeking affordable, prescription-strength weight management without insurance or in-person clinic visits. Patients complete an online intake form, undergo provider review, and receive medication from a U.S. 503A partner pharmacy if approved. The model is designed for cost-conscious, self-directed users who already understand GLP-1 therapy.

Brello’s product lineup extends beyond GLP-1 medications. The platform also offers NAD+ starting at $66 per month, Sermorelin at $116 per month, and an Empowered+ plan combining GLP-1 and NAD+ starting at $199 per month. The company markets primarily to women, with a focus on longevity medicine alongside weight management.

What Medications Does Brello Health Offer?

Brello Health offers compounded semaglutide with B6 starting at $133 per month and compounded tirzepatide with B6 starting at $166 per month — both requiring a 3-month minimum commitment billed upfront at $399 and $499 respectively. The active ingredients match those in Ozempic, Wegovy, Mounjaro, and Zepbound, but the compounded formulations are not FDA-approved.

The addition of B6 (pyridoxine) to both formulations is a distinguishing feature. B6 is included to support energy levels and reduce nausea during the early weeks of GLP-1 therapy. The inclusion is based on pyridoxine’s role in neurotransmitter synthesis and its established anti-nausea properties — the same reason B6 is used in pregnancy nausea treatment.

No branded alternatives like Ozempic or Zepbound are available through Brello. Only compounded injectable formulations are offered. Oral GLP-1 options are also not available through the platform, limiting flexibility for patients who prefer non-injectable administration routes.

Brello Health Medication Options:

Compounded semaglutide with B6 — $399 per 3 months ($133/month)
Compounded tirzepatide with B6 — $499 per 3 months ($166/month)
NAD+ — starting at $66/month
Sermorelin — starting at $116/month
Empowered+ (GLP-1 + NAD+) — starting at $199/month

How Does Brello Health Work Step by Step?

The enrollment process starts with selecting a plan and completing an online intake form — but payment is collected before clinical approval occurs. This is a key distinction from platforms like Remedy Meds, where clinician review happens before payment. At Brello, you pay first, then a licensed clinician reviews your eligibility independently. Approval is not guaranteed after payment.

If approved, the assigned compounding pharmacy prepares and ships the medication. Shipping normally takes 5-7 business days, though delays of 4-6 weeks have been documented during pharmacy facility transitions. Monthly check-ins occur through the Brello app, which includes one-on-one provider messaging, progress tracking, and access to virtual fitness and nutrition classes via Brello Rise.

Ongoing support includes a private Facebook community, educational resources, and access to accountability tools through the app. The screening process is described as ‘light’ compared to competitors — the intake form covers health history and goals, but the depth of clinician review before prescribing is less rigorous than platforms with synchronous video consultations required before approval.

How It Works:

Select a plan and complete the online intake form (payment collected upfront before approval)

A licensed clinician reviews your eligibility independently after payment
If approved, medication ships from a U.S. 503A compounding pharmacy (5-7 business days standard)
Monthly check-ins via the Brello app with provider messaging and progress tracking

What Are the Ingredients in Brello Health’s Medications?

Brello Health medications contain semaglutide or tirzepatide as the active pharmaceutical ingredient, combined with pyridoxine (B6), and compounded by U.S. 503A licensed pharmacies. The active compounds are identical to those in FDA-approved brand-name drugs. The B6 addition and compounding process are the distinguishing formulation choices Brello makes compared to platforms that offer standard compounded GLP-1s without additives.

Compounding pharmacies operate under state board of pharmacy oversight and are subject to inspections, but they do not undergo the same pre-market FDA review as brand-name drug manufacturers. Brello does not publicly name its pharmacy partners, which reduces transparency compared to platforms that disclose specific compounding pharmacy relationships. This anonymity is a documented concern among reviewers.

The important distinction to understand: compounded semaglutide and tirzepatide contain the same core active ingredients as Ozempic, Wegovy, Mounjaro, and Zepbound but have not been evaluated by the FDA for safety, quality, or efficacy. Patients choosing Brello’s compounded formulations accept this regulatory trade-off in exchange for significantly lower monthly costs.

What Is Semaglutide With B6 and How Does It Work?

Semaglutide activates GLP-1 receptors in the brain and pancreas, slowing gastric emptying, suppressing appetite signals, and promoting insulin secretion in response to food — and Brello’s B6 addition targets the nausea that most new users experience during the titration phase. The GLP-1 receptor activation is the core weight loss mechanism. Pyridoxine (B6) is added as an anti-nausea co-factor, addressing the most common early barrier to staying on the medication.

Brello’s semaglutide is administered as a once-weekly subcutaneous injection. Dosage increases gradually over the titration schedule managed through monthly app check-ins. Standard clinical trials on branded semaglutide (STEP trials) showed an average body weight reduction of 14.9% over 68 weeks, which is the benchmark Brello’s compounded version is measured against.

At $133 per month, Brello’s semaglutide is among the lowest-priced compounded options on the market. For context, competing platforms like Remedy Meds charge $299 per month and brand-name Wegovy costs approximately $1,349 per month without insurance. The price difference is significant — the tradeoff is the support structure and pharmacy transparency that come with higher-priced alternatives.

What Is Tirzepatide With B6 and How Does It Work?

Tirzepatide activates both GIP and GLP-1 receptors simultaneously, producing stronger appetite suppression and blood sugar regulation than semaglutide’s single-agonist mechanism — Brello adds B6 to the formulation for the same nausea-mitigation purpose as in its semaglutide plan. The dual-hormone action makes tirzepatide the higher-potency option for patients who have plateaued on semaglutide or who need more aggressive intervention from the start.

Brello’s tirzepatide plan costs $499 per 3 months — $166 per month. This compares to $399 per month at Remedy Meds and approximately $1,000+ per month for brand-name Zepbound without insurance. The cost advantage is substantial. The limitations are the same as with the semaglutide plan: unnamed pharmacy partners, light screening, and documented shipping delays.

SURMOUNT-1 trials on branded tirzepatide showed up to 22.5% average body weight reduction over 72 weeks. Brello’s compounded version contains the same active ingredient but has not been independently evaluated for purity, potency, or efficacy. Patients choosing the tirzepatide plan at this price point accept that regulatory uncertainty as a cost-of-access trade-off.

Does Brello Health Actually Produce Weight Loss Results?

Yes. Brello Health’s medications contain the same active ingredients as clinically validated GLP-1 drugs, and the underlying STEP and SURMOUNT trial data supports meaningful weight loss when semaglutide and tirzepatide are used correctly. Brello does not publish its own internal outcome data the way some competitors do. Results depend on medication adherence, dosage titration, and lifestyle factors.

The GLP-1 medications Brello prescribes have robust independent clinical backing. STEP trials showed 14.9% average body weight reduction over 68 weeks on semaglutide. SURMOUNT-1 trials showed up to 22.5% reduction over 72 weeks on tirzepatide. Both figures represent branded, FDA-approved versions — compounded formulations contain the same active ingredients but have not been independently validated for equivalent potency.

Real-world user reports on Trustpilot and review platforms show a range of outcomes. Positive reviewers report 15-30 lbs (7-14 kg) lost in the first 3 months when medication arrives on schedule and titration proceeds normally. Negative reviewers who experienced shipping delays of 4-6 weeks report delayed results simply due to not having the medication during that period — not due to the medication failing when used.

What Do Brello Health Reviews Say?

Brello Health holds a 3.9 to 4.0 out of 5 rating on Trustpilot with over 3,100 reviews — a lower aggregate score than premium competitors like Remedy Meds (4.3) and reflects the operational issues that accompany the platform’s budget positioning. The rating is not driven by poor medication outcomes but by fulfillment, shipping, and customer service failures that affect a significant minority of users.

Review distribution shows two clear camps. Satisfied users report fast delivery when orders are placed outside pharmacy transition periods, with some receiving medication within 3 days of intake completion. Dissatisfied users document weeks of silence from customer service, delayed shipments with no status updates, and billing disputes after attempted cancellations.

The GLP-1 Match platform gives Brello a positive assessment for pricing transparency and access, noting it as a legitimate option for cost-conscious patients. Independent review sites consistently flag the unnamed pharmacy partner, light screening process, and payment-before-approval model as the primary structural concerns — not the medication’s effectiveness when it arrives.

What Are the Positive Experiences From Users?

Positive reviewers consistently highlight Brello’s pricing as the primary reason for choosing the platform: at $133 per month for semaglutide, no competing telehealth provider offers a comparable active-ingredient medication at a lower price point. Users who entered during non-transition periods report receiving medication within 3-7 days and describe the intake process as straightforward and low-friction.

Weight loss outcomes receive strong praise from users who complete the titration protocol successfully. Reviewers report losing 15-25 lbs (7-11 kg) within the first 3 months, with reduced appetite cited as the most noticeable early effect. Access to virtual fitness classes through Brello Rise and the private Facebook community receives positive mentions for accountability support.

Customer service responsiveness is praised in positive reviews, with some users reporting quick replies via the app messaging system when the pharmacy is operating normally. The B6 formulation is specifically mentioned by multiple users as reducing the nausea they experienced on semaglutide from previous providers — a differentiator that matters to users with prior GLP-1 experience.

What Are the Most Common Complaints?

The most severe complaint pattern involves shipping delays of 4-6 weeks or longer, compounded by customer service going silent during pharmacy facility transitions — with some users waiting 3+ months after payment without receiving medication or status updates. BBB complaints document orders placed in November 2025 that remained unfulfilled as of February 2026. Phone calls, texts, and emails went unanswered during these periods.

The payment-before-approval model generates a second category of complaints. Patients pay $399-$499 upfront before any clinician reviews their case. Those who are denied prescriptions or who face state licensing gaps report difficulty obtaining refunds. One documented case involved a patient sold medication in a state where Brello had not yet secured the required license — leading to a protracted delay with no resolution pathway.

Billing practices create a third complaint thread. Pausing a subscription through the website but then completing a monthly check-in survey has triggered unauthorized renewals and unwanted medication shipments in documented BBB cases. The line between ‘paused’ and ‘active’ is not clearly communicated, and the financial consequences of this ambiguity fall on the patient.

What Are the Side Effects of Brello Health Medications?

The most common side effects of Brello’s compounded GLP-1 medications are gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal pain affect most new users in the first weeks of treatment, and Brello’s B6 formulation is specifically designed to reduce the severity of these symptoms. For many users, the B6 addition meaningfully blunts the nausea that peaks during the titration phase.

Common Side Effects:

Nausea, vomiting, diarrhea, constipation
Abdominal pain and bloating
Headache and fatigue
Dizziness
Injection site reactions: swelling, redness, itchiness

Systemic side effects are also reported. Headache, fatigue, dizziness, and injection site reactions affect a subset of users. These effects typically diminish as patients progress through the titration protocol. The gradual weekly dose increase is designed to minimize side effect severity while allowing the body to adjust to GLP-1 receptor activation.

Serious Side Effects (Require Immediate Medical Attention):

Acute pancreatitis (severe abdominal pain)
Gallbladder disease or gallstones
Acute kidney injury
Severe allergic reactions
Vision changes (diabetic retinopathy risk)
Suicidal thoughts or behavioral changes
Increased heart rate

The FDA has issued a boxed warning for all GLP-1 medications for a potential link to medullary thyroid carcinoma (MTC). Animal studies showed thyroid tumors in mice and rats at doses comparable to human treatment levels. Human risk is not established, but ongoing clinician monitoring throughout treatment is required.

Who Should Avoid Brello Health?

Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) must not use any GLP-1 medication, including Brello’s compounded versions — this is an absolute contraindication tied to the FDA’s boxed warning for GLP-1 drug class thyroid risk. This exclusion applies regardless of price or platform.

Pregnancy and breastfeeding are absolute contraindications for compounded semaglutide and tirzepatide. Animal studies show potential fetal harm from both compounds during gestation. Patients planning pregnancy should discontinue GLP-1 therapy at least 2 months before attempting conception.

Who Should Not Use Brello Health:

Personal or family history of medullary thyroid carcinoma (MTC) or MEN 2
Pregnant or breastfeeding patients
Patients who need extensive medical supervision or complex history review

Patients requiring month-to-month flexibility (3-month commitment required)
Patients who need microdosing or custom titration protocols
Patients who want fastest possible delivery (shipping delays are documented)

Is Brello Health Legit and Safe?

Yes. Brello Health is a legitimate telehealth operation: U.S.-based, clinician-staffed, transparent about its non-FDA-approved medications, and sourcing from licensed U.S. 503A compounding pharmacies. The platform holds a 3.9-4.0 Trustpilot rating across 3,100+ reviews and has served over 80,000 active members. Licensed clinicians control prescribing and no adverse clinical safety incidents appear in documented complaints — the complaints are operational, not medical.

That said, Brello’s legitimacy comes with important caveats. The pharmacy partners are not publicly named, reducing transparency about where medications are compounded. The payment-before-approval model creates financial risk if prescriptions are denied or state licensing gaps exist. The light screening process means less clinical oversight than platforms requiring synchronous video consultations before prescribing.

The compounded medications are legal but carry the same regulatory uncertainty as all non-FDA-approved compounded drugs. Brello clearly discloses this on its platform. The FDA has not issued a warning letter to Brello specifically, unlike Remedy Meds, which received one in September 2025 for misleading claims. Brello’s compliance posture on claims appears more conservative.

Is Brello Health FDA Approved?

No. Compounded semaglutide and tirzepatide are not FDA-approved; they are produced by licensed U.S. 503A compounding pharmacies and are legal to prescribe but have not passed the FDA’s pre-market evaluation for safety, quality, or efficacy. Brello clearly discloses this on its platform — a transparency point that distinguishes it from providers who obscure this status in their marketing.

FDA-approved alternatives use the same active ingredients under brand names: Ozempic and Wegovy for semaglutide, Mounjaro and Zepbound for tirzepatide. These are not available through Brello. Patients who require FDA-approved medications will need to use a different platform. The price of brand-name Wegovy without insurance is approximately $1,349 per month — roughly 10x Brello’s semaglutide starting price.

The broader regulatory environment for compounded GLP-1 providers has tightened significantly in 2025-2026. Increased FDA enforcement, warning letters to multiple platforms, and pharmacy shortfall declarations are reshaping the market. Brello’s unnamed pharmacy partner structure introduces some uncertainty about how it would navigate further regulatory changes in this space.

Brello Health vs Remedy Meds vs Mochi Health: Which Is Better?

Brello Health is the lowest-cost option at $133-$166 per month, compared to Remedy Meds at $299-$399 per month and Mochi Health at approximately $99 per month for the platform plus separate medication costs — but the pricing difference reflects meaningful differences in support depth, pharmacy transparency, and operational reliability.

Remedy Meds offers more robust support: named pharmacy partnerships, a 365-day money-back guarantee, unlimited clinician access, and a payment-after-approval model. Mochi Health provides more comprehensive medical oversight including registered dietitian access but charges separately for medication. Both competitors offer stronger accountability structures than Brello’s budget model.

Platform Comparison:

Feature	Brello Health	Remedy Meds	Mochi Health
Semaglutide Cost	$133/month (3-mo commitment)	$299/month	~$99 platform + medication
Payment Timing	Before approval	After approval	After approval
Pharmacy Transparency	Unnamed partners	Named U.S. 503A pharmacies	Disclosed partners
Money-Back Guarantee	Not listed	365-day guarantee	None listed
B6 in Formulation	Yes	No	No
Best For	Budget-first self-directed users	Cash-pay patients wanting support	Patients wanting dietitian access

Bottom line: choose Brello if lowest price is the priority and you’re comfortable with a self-directed approach. Choose Remedy Meds for better support and billing transparency. Choose Mochi Health for clinical depth beyond medication management.

How Much Does Brello Health Cost?

Brello Health charges $399 per 3-month supply of compounded semaglutide with B6 ($133/month) and $499 per 3-month supply of compounded tirzepatide with B6 ($166/month) — both billed upfront with a 3-month minimum commitment. No month-to-month option exists at the starting price point. HSA and FSA eligibility may apply; insurance is not accepted.

Brello Health Pricing Overview:

Plan	Upfront Cost	Per Month	What’s Included
Compounded Semaglutide + B6	$399 per 3 months	$133	Medication, provider review, syringes, app access, virtual classes, community
Compounded Tirzepatide + B6	$499 per 3 months	$166	Same as above; dual-receptor medication
Empowered+ (GLP-1 + NAD+)	Varies	From $199	GLP-1 medication plus NAD+ longevity protocol

The 3-month upfront commitment is the main flexibility trade-off. Patients who are denied prescriptions after payment, or who experience shipping delays, face a longer path to refund resolution compared to month-to-month platforms. The renewal pricing after the initial 3-month period is higher than the introductory rate — a detail worth confirming before re-enrolling.

Is Brello Health Worth the Price?

At $133 per month for semaglutide, Brello Health offers the lowest price point among established compounded GLP-1 telehealth platforms — and for self-directed patients who understand GLP-1 therapy, it delivers the active medication at a fraction of what competitors charge. The value is real if you receive the medication without delay and don’t require ongoing clinical support.

The value calculation shifts significantly if shipping delays occur. A 6-week delay on a 3-month supply paid upfront means paying $133 per month while receiving no medication for the first month and a half. In that scenario, the effective cost per month of actual treatment rises substantially. Factor in the absence of a money-back guarantee and the value proposition weakens further.

For patients who are knowledgeable about GLP-1 medications, comfortable with self-directed management, and outside of periods of pharmacy transition, Brello delivers strong cost efficiency. For patients who need hand-holding, medical oversight, or guaranteed delivery timelines, the price premium at a platform like Remedy Meds is justified by operational reliability.

Where Can You Buy Brello Health?

Brello Health is available exclusively through brellohealth.com and operates in most U.S. states, with a live availability map on the enrollment page showing real-time state coverage before patients commit to payment. The fully digital process requires no in-person visits or pharmacy pickups. State availability has changed after enrollment for some customers, so confirming eligibility before payment is essential.

Customer support is accessible via the Brello app messaging system, email, and phone. During pharmacy facility transitions, support responsiveness has dropped significantly based on documented complaints. The company’s support hours and response time commitments are not prominently stated on the website, which contributes to frustration during fulfillment delays.

Medication ships from a U.S. 503A compounding pharmacy within 5-7 business days under normal operating conditions. Delays of 4-6 weeks or longer have occurred during facility transitions. Patients should confirm current shipping status with customer service before purchasing, particularly if they need medication to arrive by a specific date.

Should You Try Eat Proteins’ Approach Instead of Brello Health?

Before committing $399 upfront for a medication that might take 6 weeks to arrive, consider whether the underlying problem requires a drug at all. Eat Proteins offers evidence-based protein optimization protocols that activate the same satiety mechanisms as GLP-1 medications — without injections, compounding pharmacy uncertainty, or upfront 3-month financial commitments.

Here’s the science: high protein intake increases satiety hormones and reduces ghrelin, the hunger signal. That’s the same appetite-suppression pathway that semaglutide and tirzepatide target pharmacologically. Protein-first protocols produce meaningful weight loss for people with moderate goals — without thyroid cancer boxed warnings, unnamed pharmacy partners, or billing disputes triggered by check-in surveys.

GLP-1 medications are the right tool for clinically severe obesity. But for most people exploring weight management for the first time, our coaches at Eat Proteins can guide you through a research-backed nutrition protocol that costs a fraction of any GLP-1 subscription — and works from day one, not after a 6-week shipping delay. Sign up below to get started.

Brello Health Review: Is This GLP-1 Provider Worth It?